A 69-year-old postmenopausal woman with osteoporosis presents with BP 138/82, HR 78, RR 16, afebrile, SpO2 98% on room air. Recent DEXA scan shows T-score of -2.8 at the femoral neck. She denies dysphagia or reflux symptoms. Started on a medication that binds hydroxyapatite and inhibits osteoclast-mediated bone resorption. She receives strict counseling to remain upright 30 minutes postdose to minimize esophageal injury risk. Which drug was most likely prescribed?
- A)Teriparatide
- B)AlendronateGABARITO
- C)Calcitonin
- D)Raloxifene
- E)Cinacalcet
Explicação
Alendronate is a bisphosphonate that inhibits osteoclast mediated bone resorption. Esophagitis is a classic adverse effect, so patients are instructed to take it with water and remain upright afterward. Ver explicação completa e trilha adaptativa →